Zarathustra
-
Total Posts
:
140
-
Reward points
:
0
- Joined: Jan 28, 2009
- Location: Virginia, USA, North America
|
Chili Extract possible cure for diabetes.
-
Mar 29, 2009 13:53
Scientists have discovered that after injecting capsaicin, a chili extract, insulin levels increased and restored blood glucose levels to normal virtually overnight. This discovery of the role for sensory nerves in diabetes opens door to new treatment strategies. Researchers at Toronto University in Canada found the injectable cure after successful tests on mice and believe it will transform the quality of life of tens of million of people. Researchers at The Hospital for Sick Children (SickKids), the University of Calgary and The Jackson Laboratory, Bar Harbor, Maine have found that diabetes is controlled by abnormalities in the sensory nociceptor (pain-related) nerve endings in the pancreatic islet cells that produce insulin. This discovery, a breakthrough that has long been the elusive goal of diabetes research, has led to new treatment strategies for diabetes, achieving reversal of the disease without severe, toxic immunosuppression.
When the mice’s pancreatic sensory nerves were injected with the substance, they began producing insulin normally almost instantaneously. Trials on humans with type one and type two diabetes are expected to begin within the next six months.
One of the doctors leading the research, Michael Dosch, said that with similar results in humans, one injection could keep diabetes at bay for years. Dosch described the research as “stunning”. Christian Stohler of the University of Maryland, who reviewed the research, said it opened “a novel, exciting door to address one of the diseases with large societal impact”.
The researchers also concluded that type one and type two diabetes are more alike than previously thought and found that nerves can play a role in other chronic inflammatory conditions such as inflammatory bowel disease and asthma.
Type 1 diabetes is an autoimmune disorder that affects more than ten per cent of the 21 million diagnosed with diabetes. Studies have focused on the immune system as the sole offender and research into the fundamental mechanisms of the disease have been overdue. Pancreatic islet cells, the cells responsible for the production of pancreatic hormones such as insulin, play a key role in the disease. In diabetes, islets become inflamed and are ultimately destroyed, making insulin production impossible. Insulin deficiency is fatal and current insulin replacement therapies cannot prevent many side effects such as heart attacks, blindness, strokes, loss of limbs and kidney function.
The SickKids research group has long been pursuing links between diabetes and the nervous system, studying both humans and animal models of the disease. Recently, the group found an unsuspected control circuit between insulin-producing islets and their associated sensory or pain nerves. This circuit sustains normal islet function.
“We started to look at nervous system elements that seemed to play a role in Type 1 diabetes and found that specific sensory neurons are critical for islet immune attack in the pancreas,” said Dr. Hans Michael Dosch, study principal investigator, senior scientist at SickKids and professor of Paediatrics and Immunology at the University of Toronto. “These nerves secrete insufficient neuropeptides which sustain normal islet function, creating a vicious circle of progressive islet stress.”
Using diabetes-prone NOD mice, the gold-standard diabetes model, the research group learned how to treat the abnormality by supplying neuropeptides and even reversed established diabetes.
“The major discovery was that removal of sensory neurons expressing the receptor TRPV1 neurons in NOD mice prevented islet cell inflammation and diabetes in most animals, which led us to fundamentally new insights into the mechanisms of this disease,” said Dr. Michael Salter, co-principal investigator, senior scientist at SickKids, professor of Physiology and director of the Centre for the Study of Pain at the University of Toronto. “Disease protection occurred despite the fact that autoimmunity continues in the animals. This helped us to focus our studies on finding the new control circuit in the islets.”
Strikingly, injection of the neuropeptide substance P cleared islet inflammation in NOD mice within a day and independently normalized the elevated insulin resistance normally associated with the disease. The two effects synergized to reverse diabetes without severely toxic immunosuppression.
The studies were extended to Type 2 (obesity-associated) diabetes, in which insulin resistance is even more severe, using a number of additional model systems, thus generating strong evidence that treating the islet-sensory nerve circuit can work to dramatically normalize insulin resistance in models of Type 2 diabetes.
“This discovery opens up an entirely new field of investigations in Type 1 and possibly Type 2 diabetes, as well as tissue selective autoimmunity in general,” said Dr. Pere Santamaria, study collaborator and professor of Microbiology and Infectious Diseases at the University of Calgary. “We have created a better understanding of both Type 1 and Type 2 diabetes, with new therapeutic targets and approaches derived for both diseases.”
|